{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:33:43Z","timestamp":1791275623137,"version":"4.1.0"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"16","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The matrix metalloproteinases MMP-2, MMP-3, MMP-7, MMP-9, and MMP-13 are highly expressed in the tumor-bone microenvironment, and, of these, MMP-7 and MMP-9 were found to be localized to bone-resorbing osteoclasts in human breast-to-bone metastases. In a bid to define the roles of host-derived MMP-7 and MMP-9 in the tumor-bone microenvironment, the tibias of MMP-7 and MMP-9 null mice were injected with osteolytic luciferase\u2013tagged mammary tumor cell lines. Our data show that osteoclast-derived MMP-7 significantly contributes to tumor growth and tumor-induced osteolysis whereas osteoclast-derived MMP-9 had no effect on these processes. MMP-7 is capable of processing a number of nonmatrix molecules to soluble active forms that have profound effects on cell-cell communication, such as RANKL, a crucial mediator of osteoclast precursor recruitment and maturation. Therefore, the ability of osteoclast-derived MMP-7 to promote RANKL solubilization in the tumor-bone microenvironment was explored. Results revealed that levels of soluble RANKL were significantly lower in the MMP-7 null mice compared with wild-type (WT) controls. In keeping with this observation, MMP-7 null mice had significantly fewer osteoclast numbers at the tumor-bone interface compared with the WT controls. In summary, we propose that the solubilization of RANKL by MMP-7 is a potential mechanism through which MMP-7 mediates mammary tumor\u2013induced osteolysis. Our studies indicate that the selective inhibition of MMP-7 in the tumor-bone microenvironment may be of benefit for the treatment of lytic breast-to-bone metastases. [Cancer Res 2009;69(16):6747\u201355]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3949","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T00:38:56Z","timestamp":1250123936000},"page":"6747-6755","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Osteoclast-Derived Matrix Metalloproteinase-7, but Not Matrix Metalloproteinase-9, Contributes to Tumor-Induced Osteolysis"],"prefix":"10.1158","volume":"69","author":[{"given":"Sophie","family":"Thiolloy","sequence":"first","affiliation":[{"name":"1Cancer Biology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Halpern","sequence":"additional","affiliation":[{"name":"2Orthopaedics and Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger E.","family":"Holt","sequence":"additional","affiliation":[{"name":"2Orthopaedics and Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert S.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"2Orthopaedics and Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Mundy","sequence":"additional","affiliation":[{"name":"3Vanderbilt Center for Bone Biology, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Matrisian","sequence":"additional","affiliation":[{"name":"2Orthopaedics and Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor C.","family":"Lynch","sequence":"additional","affiliation":[{"name":"1Cancer Biology, Departments of"},{"name":"2Orthopaedics and Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,8,12]]},"reference":[{"key":"2022061701483952800_B1","doi-asserted-by":"crossref","unstructured":"Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer\u20081987; 55: 61\u20136.","DOI":"10.1038\/bjc.1987.13"},{"key":"2022061701483952800_B2","doi-asserted-by":"crossref","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer\u20082002; 2: 584\u201393.","DOI":"10.1038\/nrc867"},{"key":"2022061701483952800_B3","doi-asserted-by":"crossref","unstructured":"Chirgwin JM, Guise TA. Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryot Gene Expr\u20082000; 10: 159\u201378.","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50"},{"key":"2022061701483952800_B4","doi-asserted-by":"crossref","unstructured":"Compston JE. Bone marrow and bone: a functional unit. J Endocrinol\u20082002; 173: 387\u201394.","DOI":"10.1677\/joe.0.1730387"},{"key":"2022061701483952800_B5","doi-asserted-by":"crossref","unstructured":"Delaisse JM, Engsig MT, Everts V, et al. Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta\u20082000; 291: 223\u201334.","DOI":"10.1016\/S0009-8981(99)00230-2"},{"key":"2022061701483952800_B6","doi-asserted-by":"crossref","unstructured":"Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech\u20082003; 61: 504\u201313.","DOI":"10.1002\/jemt.10374"},{"key":"2022061701483952800_B7","doi-asserted-by":"crossref","unstructured":"Saftig P, Hunziker E, Wehmeyer O, et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A\u20081998; 95: 13453\u20138.","DOI":"10.1073\/pnas.95.23.13453"},{"key":"2022061701483952800_B8","doi-asserted-by":"crossref","unstructured":"Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst\u20081997; 89: 1260\u201370.","DOI":"10.1093\/jnci\/89.17.1260"},{"key":"2022061701483952800_B9","doi-asserted-by":"crossref","unstructured":"Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation\u20082002; 70: 561\u201373.","DOI":"10.1046\/j.1432-0436.2002.700909.x"},{"key":"2022061701483952800_B10","doi-asserted-by":"crossref","unstructured":"Lee J, Weber M, Mejia S, Bone E, Watson P, Orr W. A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu\/nu mice. Eur J Cancer\u20082001; 37: 106\u201313.","DOI":"10.1016\/S0959-8049(00)00363-4"},{"key":"2022061701483952800_B11","unstructured":"Winding B, NicAmhlaoibh R, Misander H, et al. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. Clin Cancer Res\u20082002; 8: 1932\u20139."},{"key":"2022061701483952800_B12","doi-asserted-by":"crossref","unstructured":"Nemeth JA, Yousif R, Herzog M, et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst\u20082002; 94: 17\u201325.","DOI":"10.1093\/jnci\/94.1.17"},{"key":"2022061701483952800_B13","doi-asserted-by":"crossref","unstructured":"Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science\u20082002; 295: 2387\u201392.","DOI":"10.1126\/science.1067100"},{"key":"2022061701483952800_B14","doi-asserted-by":"crossref","unstructured":"Lynch CC, Hikosaka A, Acuff HB, et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell\u20082005; 7: 485\u201396.","DOI":"10.1016\/j.ccr.2005.04.013"},{"key":"2022061701483952800_B15","doi-asserted-by":"crossref","unstructured":"Halpern J, Lynch CC, Fleming J, et al. The application of a murine bone bioreactor as a model of tumor: bone interaction. Clin Exp Metastasis\u20082006; 23: 345\u201356.","DOI":"10.1007\/s10585-006-9044-8"},{"key":"2022061701483952800_B16","unstructured":"Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res\u20081992; 52: 1399\u2013405."},{"key":"2022061701483952800_B17","doi-asserted-by":"crossref","unstructured":"Fingleton B, Powell WC, Crawford HC, Couchman JR, Matrisian LM. A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo. Hybridoma (Larchmt)\u20082007; 26: 22\u20137.","DOI":"10.1089\/hyb.2006.028"},{"key":"2022061701483952800_B18","doi-asserted-by":"crossref","unstructured":"Filgueira L. Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J Histochem Cytochem\u20082004; 52: 411\u20134.","DOI":"10.1177\/002215540405200312"},{"key":"2022061701483952800_B19","doi-asserted-by":"crossref","unstructured":"Engsig MT, Chen QJ, Vu TH, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol\u20082000; 151: 879\u201390.","DOI":"10.1083\/jcb.151.4.879"},{"key":"2022061701483952800_B20","doi-asserted-by":"crossref","unstructured":"Martin M, Carter K, Thiolloy S, Lynch CC, Matrisian L, Fingleton B. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res\u20082008; 68: 6251\u20139.","DOI":"10.1158\/0008-5472.CAN-08-0537"},{"key":"2022061701483952800_B21","doi-asserted-by":"crossref","unstructured":"Nabha SM, Bonfil RD, Yamamoto HA, et al. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis. Clin Exp Metastasis\u20082006; 23: 335\u201344.","DOI":"10.1007\/s10585-006-9042-x"},{"key":"2022061701483952800_B22","doi-asserted-by":"crossref","unstructured":"Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin (MMP-7) proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Bio\u20081999; 9: 1441\u20137.","DOI":"10.1016\/S0960-9822(00)80113-X"},{"key":"2022061701483952800_B23","doi-asserted-by":"crossref","unstructured":"Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-\u03b1 in a model of herniated disc resorption. J Clin Invest\u20082000; 105: 143\u201350.","DOI":"10.1172\/JCI7091"},{"key":"2022061701483952800_B24","doi-asserted-by":"crossref","unstructured":"Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature\u20081999; 397: 315\u201323.","DOI":"10.1038\/16852"},{"key":"2022061701483952800_B25","doi-asserted-by":"crossref","unstructured":"Breuil V, Schmid-Antomarchi H, Schmid-Alliana A, Rezzonico R, Euller-Ziegler L, Rossi B. The receptor activator of nuclear factor (NF)-\u03baB ligand (RANKL) is a new chemotactic factor for human monocytes. FASEB J\u20082003; 17: 1751\u20133.","DOI":"10.1096\/fj.02-1188fje"},{"key":"2022061701483952800_B26","doi-asserted-by":"crossref","unstructured":"Lum L, Wong BR, Josien R, et al. Evidence for a role of a tumor necrosis factor-\u03b1 (TNF-\u03b1)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem\u20081999; 274: 13613\u20138.","DOI":"10.1074\/jbc.274.19.13613"},{"key":"2022061701483952800_B27","doi-asserted-by":"crossref","unstructured":"Schlondorff J, Lum L, Blobel CP. Biochemical and pharmacological criteria define two shedding activities for TRANCE\/OPGL that are distinct from the tumor necrosis factor \u03b1 convertase. J Biol Chem\u20082001; 276: 14665\u201374.","DOI":"10.1074\/jbc.M010741200"},{"key":"2022061701483952800_B28","doi-asserted-by":"crossref","unstructured":"Wilson TJ, Nannuru KC, Futakuchi M, Sadanandam A, Singh RK. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-\u03baB ligand. Cancer Res\u20082008; 68: 5803\u201311.","DOI":"10.1158\/0008-5472.CAN-07-5889"},{"key":"2022061701483952800_B29","doi-asserted-by":"crossref","unstructured":"Blair HC. How the osteoclast degrades bone. Bioessays\u20081998; 20: 837\u201346.","DOI":"10.1002\/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D"},{"key":"2022061701483952800_B30","doi-asserted-by":"crossref","unstructured":"Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem\u20082001; 276: 28261\u20137.","DOI":"10.1074\/jbc.M103608200"},{"key":"2022061701483952800_B31","doi-asserted-by":"crossref","unstructured":"Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-\u03b2 1 release. Biochem J\u20081997; 322: 809\u201314.","DOI":"10.1042\/bj3220809"},{"key":"2022061701483952800_B32","doi-asserted-by":"crossref","unstructured":"Miyamoto S, Yano K, Sugimoto S, et al. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res\u20082004; 64: 665\u201371.","DOI":"10.1158\/0008-5472.CAN-03-1916"},{"key":"2022061701483952800_B33","doi-asserted-by":"crossref","unstructured":"Burke B, Giannoudis A, Corke KP, et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol\u20082003; 163: 1233\u201343.","DOI":"10.1016\/S0002-9440(10)63483-9"},{"key":"2022061701483952800_B34","unstructured":"Athanasou NA, Sabokbar A. Human osteoclast ontogeny and pathological bone resorption. Histol Histopathol\u20081999; 14: 635\u201347."},{"key":"2022061701483952800_B35","doi-asserted-by":"crossref","unstructured":"Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia\u20082001; 3: 459\u201368.","DOI":"10.1038\/sj.neo.7900190"},{"key":"2022061701483952800_B36","doi-asserted-by":"crossref","unstructured":"Sawey ET, Johnson JA, Crawford HC. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc Natl Acad Sci U S A\u20082007; 104: 19327\u201332.","DOI":"10.1073\/pnas.0705953104"},{"key":"2022061701483952800_B37","doi-asserted-by":"crossref","unstructured":"Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A\u20081997; 94: 1402\u20137.","DOI":"10.1073\/pnas.94.4.1402"},{"key":"2022061701483952800_B38","doi-asserted-by":"crossref","unstructured":"Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal \u03b1-defensin activation by the metalloproteinase matrilysin in innate host defense. Science\u20081999; 286: 113\u20137.","DOI":"10.1126\/science.286.5437.113"},{"key":"2022061701483952800_B39","doi-asserted-by":"crossref","unstructured":"Rudolph-Owen LA, Matrisian LM. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia\u20081998; 3: 177\u201389.","DOI":"10.1023\/A:1018746923474"},{"key":"2022061701483952800_B40","doi-asserted-by":"crossref","unstructured":"Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A. Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog\u20082005; 38: 97\u2013105.","DOI":"10.1016\/j.micpath.2004.12.005"},{"key":"2022061701483952800_B41","doi-asserted-by":"crossref","unstructured":"Ohta S, Imai K, Yamashita K, Matsumoto T, Azumano I, Okada Y. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest\u20081998; 78: 79\u201387.","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<187::AID-IJC15>3.0.CO;2-7"},{"key":"2022061701483952800_B42","doi-asserted-by":"crossref","unstructured":"Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment 1. Cancer Res\u20082006; 66: 259\u201366.","DOI":"10.1158\/0008-5472.CAN-05-2502"},{"key":"2022061701483952800_B43","doi-asserted-by":"crossref","unstructured":"Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol\u20082000; 2: 737\u201344.","DOI":"10.1038\/35036374"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/16\/6747\/2613352\/6747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/16\/6747\/2613352\/6747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:09:53Z","timestamp":1655442593000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/16\/6747\/549879\/Osteoclast-Derived-Matrix-Metalloproteinase-7-but"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,12]]},"references-count":43,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2009,8,12]]},"published-print":{"date-parts":[[2009,8,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3949","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499064.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499064","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378952","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378952.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,12]]}}}